Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 99

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 99
---

material to Leerink Partners’ analysis or its opinion and that, in the course of obtaining the necessary governmental, regulatory and other approvals, consents, releases and waivers for the Divestiture, as applicable, no delay, limitation,
restriction, condition or other change would be imposed, the effect of which would be material to Leerink Partners’ analysis or its opinion, and that each of Aadi, Aadi Sub and Kaken would perform their respective covenants and agreements set
forth in the Divestiture Agreement in accordance with the terms of the Divestiture Agreement. Leerink Partners did not evaluate and did not express any opinion as to the solvency or fair value of Aadi, Aadi Sub or Kaken, or their respective
abilities to pay their obligations when they come due, or as to the impact of the Divestiture on such matters, under any state, federal or other laws relating to bankruptcy, insolvency, or similar matters. Leerink Partners is not a legal,
regulatory, tax or accounting advisor, and Leerink Partners expressed no opinion as to any legal, regulatory tax or accounting matters. Leerink Partners expressed no view or opinion as to the price or range of prices at which the shares of stock or
other securities or instruments of Aadi or any third party may trade at any time, including subsequent to the announcement or consummation of the Divestiture.

Leerink Partners expressed no view as to, and the opinion of Leerink Partners did not address, Aadi’s underlying business decision to
proceed with or effect the Divestiture, or the relative merits of the Divestiture as compared to any alternative business strategies or transactions that might be available to Aadi or in which Aadi might engage. The opinion of Leerink Partners was
limited to and addressed only the fairness, from a financial point of view, as of the date of the opinion, to Aadi of the consideration proposed to be paid to Aadi pursuant to the terms of the Divestiture Agreement. Leerink Partners was not asked
to, and Leerink Partners did not, express any view on, and Leerink Partners’ opinion did not address, any other term or aspect of the Divestiture Agreement or the Divestiture, including, without limitation, the structure or form of
the Divestiture, or any other agreements or arrangements contemplated by the Divestiture Agreement or entered into in connection with or otherwise contemplated by the Divestiture, including, without limitation, the